The PE Ratio as of September 2024 (TTM) for Immunocore Holdings plc (IMCR) is -30.36

According to Immunocore Holdings plc’s latest financial reports and current stock price. The company's current PE Ratio is -30.36. This represents a change of -160.85% compared to the average of 49.90 of the last 4 quarters.

Immunocore Holdings plc (IMCR) Historical PE Ratio (quarterly & annually)

How has IMCR PE Ratio performed in the past?

The mean historical PE Ratio of Immunocore Holdings plc over the last ten years is -25.99. The current -30.36 PE Ratio has changed 11.58% with respect to the historical average. Over the past ten years (40 quarters), IMCR's PE Ratio was at its highest in in the September 2023 quarter at 302.53. The PE Ratio was at its lowest in in the June 2022 quarter at -54.99.

Immunocore Holdings plc (IMCR) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Immunocore Holdings plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Immunocore Holdings plc (IMCR) Average PE Ratio

How has IMCR PE Ratio performed in the past?

The current PE Ratio of Immunocore Holdings plc (IMCR) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Immunocore Holdings plc (IMCR) PE Ratio vs. Peers

How is IMCR’s PE Ratio compared to its peers?

Immunocore Holdings plc’s PE Ratio is greater than Arcellx, Inc. (-70.75), less than Ventyx Biosciences, Inc. (-0.89), less than Vaxcyte, Inc. (-26.31), less than DICE Therapeutics, Inc. (-23.17), greater than Nuvalent, Inc. (-32.10), less than Viridian Therapeutics, Inc. (-3.95), less than Gracell Biotechnologies Inc. (0), less than Theseus Pharmaceuticals, Inc. (-12.26), less than Monte Rosa Therapeutics, Inc. (-3.19), less than Design Therapeutics, Inc. (-3.11), less than Erasca, Inc. (-5.23), less than Mirum Pharmaceuticals, Inc. (-3.94), less than Larimar Therapeutics, Inc. (-18.21), less than KalVista Pharmaceuticals, Inc. (-8.80), less than Lyra Therapeutics, Inc. (-4.02), less than null (-0.18),

Build a custom stock screener for Immunocore Holdings plc (IMCR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immunocore Holdings plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Immunocore Holdings plc (IMCR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Immunocore Holdings plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.